GSK2838232 structure
|
Common Name | GSK2838232 | ||
|---|---|---|---|---|
| CAS Number | 1443461-21-9 | Molecular Weight | 809.56 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 817.1±65.0 °C at 760 mmHg | |
| Molecular Formula | C48H73ClN2O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 448.0±34.3 °C | |
Use of GSK2838232HIV-1 inhibitor-60 (compound 45) is an HIV inhibitor with the potential for the research of infection diseases[1]. |
| Name | (3beta)-3-(3-Carboxy-3-methyl-1-oxobutoxy)-17-[(1R)-2-[[(3-chlorophenyl)methyl][2-(dimethylamino)ethyl]amino]-1-hydroxyethyl]-28-norlup-18-en-21-one |
|---|---|
| Synonym | More Synonyms |
| Description | HIV-1 inhibitor-60 (compound 45) is an HIV inhibitor with the potential for the research of infection diseases[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Mark Andrew HATCHER, et al. Derivatives of botulin. Patent WO2013090664A1. |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 817.1±65.0 °C at 760 mmHg |
| Molecular Formula | C48H73ClN2O6 |
| Molecular Weight | 809.56 |
| Flash Point | 448.0±34.3 °C |
| Exact Mass | 808.515686 |
| LogP | 11.63 |
| Vapour Pressure | 0.0±3.1 mmHg at 25°C |
| Index of Refraction | 1.577 |
| 4-({(3aR,5aR,5bR,9S,11aR,11bR,13aS)-3a-[(1R)-2-{(4-Chlorobenzyl)[2-(dimethylamino)ethyl]amino}-1-hydroxyethyl]-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2H-cyclopenta[a]chrysen-9-yl}oxy)-2,2-dimethyl-4-oxobutanoic acid (non-preferred name) |
| GSK2838232 |